Pure Global

Leishmania Ab Rapid Test - India CDSCO Medical Device Registration

Leishmania Ab Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000078_99594fc3515a04388b5c9638d81ee02c_fc21d4ad87c660a1a4c1a5da4033bf3e. The license holder is Dia Sure Immunodiagnostic LLP, and it is classified as Device Class Class B. The approving authority is South Delhi Division.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Leishmania Ab Rapid Test
UID: MFG/IVD/2022/000078_99594fc3515a04388b5c9638d81ee02c_fc21d4ad87c660a1a4c1a5da4033bf3e

Device Class

Class B

Approving Authority

South Delhi Division

Product Information

Leishmania Ab Rapid Test is an immunochromatographic rapid test for qualitative detection of antibodies against Leishmania in human serum and plasma. It is for professional use only

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing